Assoc. Prof. Dr. Muhammed Mustafa Atcı

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi — Medical education

Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi — Internal Medicine residency

Cemil Taşçıoğlu Şehir Hastanesi — Medical Oncology fellowship

Tokat Devlet Hastanesi

Haseki Eğitim ve Araştırma Hastanesi

Liv Hospital Topkapı

Lung and breast cancers

Head and neck cancers

Gastrointestinal cancers

Melanoma and targeted therapies

Demircan Nazim Can, Atcı Muhammed Mustafa, et al.. "Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy." Asia-Pacific Journal of Clinical Oncology.

Gürsoy Pınar, Tatlı Ali Murat, et al.. "Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study." Journal of Cancer Research and Clinical Oncology.

Atcı Muhammed Mustafa, Akagündüz Baran, et al.. "The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study." Journal of Chemotherapy.

Bozkurt Muammer, Aghalarov Samir, Atcı Muhammed Mustafa, et al.. "A new biomarker for lung metastasis in non-seminomatous testicular cancer: De Ritis Ratio." Aktuelle Urologie.

Aktürk Esen Selin, Ergün Yakup, et al.. "First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma." Biomolecules and Biomedicine.

Çil İbrahim, Küçükarda Ahmet, Atcı Muhammed Mustafa, et al.. "Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study." Tumori Journal.

Göktaş Aydın Sabin, Çakan Demirel Burçin, et al.. "Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer." Current Medical Research and Opinion.

Hızal Mutlu, Bilgin Burak, et al.. "Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-smallcell lung cancer patients: a Turkish Oncology Group study." Future Oncology.

Dülgar Özgecan, Öven Başak Bala, Atcı Muhammed Mustafa, et al.. "Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?" Expert Review of Anticancer Therapy.

Özdemir Özlem, Zengel Baha, et al.. "The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or earlystage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study." Anti-Cancer Drugs.

Atcı Muhammed Mustafa, Akagündüz Baran, et al.. "Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study." Oncology Research and Treatment.

Ay Ersoy Seval, Atcı Muhammed Mustafa, et al.. "FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer." Journal of Chemotherapy.

Atcı Muhammed Mustafa, Pamukçu Cerciz Özgül, et al.. "The relationship between poor glycaemic control and risk factors in patients with type 2 diabetes mellitus." Eurasian Journal of Medical Advances.

Atcı Muhammed Mustafa, Sakin Abdullah, et al.. "Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer." JCPSP-Journal of The College of Physicians and Surgeons Pakistan.

Arıcı Serdar, Hamdard Jamshid, et al.. "The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment." Colorectal Disease.

Sezgin Göksu Sema, Tatlı Ali Murat, et al.. "Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck." Cancer Chemotherapy and Pharmacology.

Akagündüz Baran, Demir Metin, Atcı Muhammed Mustafa. "Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT." Journal of Gastrointestinal Cancer.

Topçu Atakan, Atcı Muhammed Mustafa, et al.. "Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer." Future Oncology.

Akagündüz Baran, Altın Zeynep, Atcı Muhammed Mustafa, et al.. "Assessment of abuse and related factors in older patients with cancer." Supportive Care in Cancer.

Akagündüz Baran, Özer Muhammet, et al.. "Impact of coronaphobia on treatment and follow-up compliance of cancer patients." Future Oncology.

Arıcı Serdar, Sağlampınar Karyağar Sevda, et al.. "The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer." Revista Española de Medicina Nuclear e Imagen Molecular.

Atcı Muhammed Mustafa, Geredeli Çağlayan, et al.. "Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study." European Journal Of Breast Health.

Sakin Abdullah, Atcı Muhammed Mustafa, et al.. "The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy." Cureus, Inc..

Sakin Abdullah, Şahin Süleyman, et al.. "The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy." Journal of Gastrointestinal Cancer.

Arıcı Serdar, Şengiz Erhan Selma, et al.. "The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy." International Journal of Hematology and Oncology.

Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al.. "The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer." Pulmonology.

Sakin Ayşegül, Şahin Süleyman, Sakin Abdullah, et al.. "Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer." Journal of Surgery and Medicine (JOSAM).

Akagündüz Baran, Akın Telli Tuğba, et al.. "Factors Affecting Survival in Retroperitoneal Sarcomas Treated with Upfront Surgery: A Real-World Study by Turkish Oncology Group." International Journal of Hematology and Oncology.

Sakin Ayşegül, Şahin Süleyman, Atcı Muhammed Mustafa, et al.. "The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy." Nutrition and Cancer.

Sakin Ayşegül, Şahin Süleyman, Sakin Abdullah, et al.. "Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis." Journal of BUON.

Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, et al.. "Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes?" Northern Clinics Of Istanbul.

Arıcı Serdar, Sağlampınar Karyağar Sevda, et al.. "The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer." Journal of Oncology Pharmacy Practice.

Sakin Abdullah, Yılmaz Ürün Yonca, et al.. "Factors Affecting Survival in Esophageal Squamous Cell Carcinoma: Single Center Experience." Northern Clinics Of Istanbul.

Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al.. "Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis." Journal of BUON.

Senocak Tasci Elif, et al.. "Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study." (2022 ASCO Gastrointestinal Cancers Symposium, Özet Bildiri/Poster)

Arıcı Serdar, Çekin Ruhper, Atcı Muhammed Mustafa. "ANDROGEN RECEPTOR STATUS IN TURKISH PATIENTS WITH HORMONE RECEPTOR POSITIVE LOCAL AND LOCALLY ADVANCED BREAST CANCER." ("6th Congress of the Mediterranean Multidisciplinary Oncology Forum" ve "3rd lnternational Congress on Oncological Sciences", Özet Bildiri/Sözlü Sunum)

C. Yazılan Ulusal/Uluslararası Kitaplar veya Kitaplardaki Bölümler

Yazılan Ulusal/Uluslararası Kitaplardaki Bölümler

Atcı Muhammed Mustafa. "MEDÜLLER TİROİD KANSERİNE YAKLAŞIM VE TAKİP". TİROİD BEZİ VE HASTALIKLARINA MULTİDİSİPLİNER YAKLAŞIM içinde. AKADEMİSYEN YAYINEVİ.

Atcı Muhammed Mustafa. "Küçük Hücreli Akciğer Kanserleri". KLİNİK ÇALIŞMALARLA ONKOLOJİDE HEDEFLİ TEDAVİLER içinde. Hipertıp Yayınevi.

Atcı Muhammed Mustafa. "Hormon Reseptör Pozitif Meme Kanserleri". KLİNİK ÇALIŞMALARLA ONKOLOJİDE HEDEFLİ TEDAVİLER içinde. Hipertıp Yayınevi.

Ay Ersoy Seval, Atcı Muhammed Mustafa, et al.. "Initial Albumin-Bilirubin Grade as a Prognostic Indicator of Pancreatic Cancer with Liver Metastasis." JOURNAL of ONCOLOGICAL SCIENCES.

Topçu Atakan, Beşiroğlu Mehmet, Atcı Muhammed Mustafa, et al.. "Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data." Eurasian Journal of Medical Investigation (EJMI).

Ay Ersoy Seval, Tataroğlu Özyükseler Deniz, et al.. "Second Line Treatment Choice in Extensive Small Lung Cancer." Eurasian Journal of Medical Investigation (EJMI).

Günay Semra, Pussane Ali Murat, et al.. "Effects of a COVID-19 Pandemic on Breast Cancer Management." European Archives of Medical Research.

Atcı Muhammed Mustafa, Can Orçun, et al.. "Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study." Journal of Oncological Sciences.

Akagündüz Baran, Güven Deniz Can, Atcı Muhammed Mustafa, et al.. "Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists." Journal of Oncological Sciences (JOS).

Atcı Muhammed Mustafa, Çekin Ruhper. "Predictive Importance of Vitamin D on Response to Neoadjuvant Chemotherapy in Turkish Patients with Locally Advanced Hormone Receptor Positive Breast Cancer." Eurasian Journal of Medical Investigation (EJMI).

Arıcı Serdar, Çekin Ruhper, et al.. "The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23 and non-small cell lung cancer." Eurasian Journal of Medical Investigation (EJMI).

Sakin Abdullah, Şahin Süleyman, Atcı Muhammed Mustafa, et al.. "The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status." Journal of Oncological Sciences (JOS).

Atcı Muhammed Mustafa. "KHDAK Tedavi Algoritması: Neoadjuvan, Adjuvan Tedavi Seçenekleri." (ULUSAL AKCİĞER SAĞLIĞI KONGRESİ, Özet Bildiri/Davetli Konuşmacı)

Dizdar Ömer, Kazaz Seher Nazlı, Atcı Muhammed Mustafa. "MULTİDİSİPLİNER TÜMÖR KONSEYİ: NONTÜBÜLER GİS TÜMÖRLERİ." (9. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Özet Bildiri/Davetli Konuşmacı)

Atcı Muhammed Mustafa. "METASTATİK YUMUŞAK DOKU SARKOMLARINDA PAZOPANİBİN ETKİNLİĞİNİN DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ." (5. Gençlerle Onkolojiye Bakış Kongresi, Özet Bildiri/Sözlü Sunum)

Hızal Mutlu, Bilgin Burak, et al.. "ALK MUTANT İLERİ EVRE KHDAK’DE BİRİNCİ BASAMAK ALEKTİNİB TEDAVİSİNİN ETKİNLİK VE GÜVENLİĞİNİN DEĞERLENDİRİLMESİ (TOG)." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Özdemir Özlem, Zengel Baha, et al.. "HER2-POZİTİF MEME KANSERİ OLAN KADINLARDA NEOADJUVAN PERTUZUMAB VE TRASTUZUMABIN ETKİNLİĞİ VE GÜVENLİĞİ: TOG ÇALIŞMASI." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa. "KANSER HASTALARINDA TEDAVİ SEÇİMİNDE BEKLENEN YAŞAM SÜRESİNİN ÖNEMİ." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Sakin Abdullah, Şahin Süleyman, Sakin Ayşegül, et al.. "PANKREAS KANSERİNDE SAĞKALIMI ETKİLEYEN FAKTÖRLER; TÜMÖR LOKALİZASYONUNUN TEDAVİ SONUÇLARI ÜZERİNE ETKİSİ VAR MIDIR?" (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Gürsoy Pınar, Tatlı Ali Murat, et al.. "Ekzon 18 Ve Ekzon 20 Mutasyon Pozitifliği Olan Hastalarda Tirozin Kinaz İnhibitörlerinin Etkinliği." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Almuradova Elvina, Başoğlu Tüylü Tuğba, et al.. "SARKOMATOİD RENAL HÜCRELİ KARSİNOM TÜRKİYE GERÇEK YAŞAM VERİLERİ." (8. Türk Tıbbi Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa. "Renal Hücreli Kanser Tedavisinde Nivolumab Tek Merkez Deneyimi." (4. Ulusal İmmünoterapi ve Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa. "Metastatik Renal Hücreli Kanser Tedavisinde İkinci Seride Aksitinib Etkinliği Tek Merkez Deneyimi." (COVID-19 Günlerinde Onkolojide Yenilikler E-Sempozyumu, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa. "The Role of Tyrosine Kinase Inhibitors in the Treatment of Advanced Medullary Thyroid Cancer." (3. Ulusal İmmünoterapi ve Onkoloji Kongresi, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa, Geredeli Çağlayan. "Meme Kanseri Tanısı Sonrası BRCA Mutasyonu Saptanan Hastaların Demografik Özellikleri." (Kanser Güncel Meme Kanseri Sempozyumu-Kanserde Güncel Gelişmeler, Özet Bildiri/Sözlü Sunum)

Atcı Muhammed Mustafa, Sağlampınar Karyağar Sevda. "Metastatik Medüller Tiroid Kanserlerinde TSH ve Tümör Yükü İlişkisi." (Sağlık Bilimleri Üniversitesi 2. İç Hastalıkları Kongresi, Tam Metin Bildiri/Sözlü Sunum)